Entrar Registro gratuito

Kazia Therapeutics Margem bruta

Qual é o Margem bruta de Kazia Therapeutics?

O Margem bruta de Kazia Therapeutics Limited é 100.00%

Qual é a definição de Margem bruta?



A margem bruta é a diferença entre a receita e o custo dos produtos vendidos, dividida por receita e expressa em porcentagem.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margem bruta de empresas na Setor Health Care em ASX em comparação com Kazia Therapeutics

O que Kazia Therapeutics faz?

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.

Empresas com margem bruta semelhantes a Kazia Therapeutics